Pacific Biosciences of California, Inc. (PACB) Shareholders’ equity 2016–2025
Pacific Biosciences of California, Inc. (PACB) shareholders’ equity at each fiscal year-end, per SEC filings.
$5.3MFY2025 · since FY2016: $84.7M → $5.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $5.3M | -98.9% |
| FY2024 | $506.6M | -27.8% |
| FY2023 | $701.3M | +24.6% |
| FY2022 | $562.9M | -28.8% |
| FY2021 | $791.0M | +135.8% |
| FY2020 | $335.5M | +510.9% |
| FY2019 | $54.9M | -51.9% |
| FY2018 | $114.1M | +32.5% |
| FY2017 | $86.1M | +1.7% |
| FY2016 | $84.7M | — |
Source: SEC XBRL filings · For reference only · Not investment advice